Catalyst Health Ventures is a venture capital firm in Massachusetts that focuses on companies operating in the healthcare, life sciences, medical devices, diagnostics, instruments and drug screening platform sectors. Founded 1998 in Braintree, Massachusetts, United State by Kevin McCafferty, it invests in early stage ventures and seed. Its portfolio companies include Aria CV, Conformal Medical, Lantos Technologies, Saphena Medical, Cruzar Medsystems, Sera Prognostics, nVision Medical, SpaceOAR, Maxwell Health, and Aria CV. As of March 2020, Catalyst Health Ventures has made 35 investments. Their most recent investment was on February 25, 2020, when Aria CV raised $31M. Catalyst Health Ventures has had seven exits, the most notable of which include Maxwell Health, GI Dynamics, and nVision Medical. The company has raised four funds, their latest being Catalyst Health Ventures IV. This fund was announced on October 23, 2019 and raised a total of $60.5M.
An insurance technology company offering a platform for employee benefits and insurance.
Hansen Medical is a healthcare company.
Sera Prognostics is a Salt Lake City-based manufacturer and supplier of diagnostic tests for possible pregnancy and birth complications.
Instylla is a Waltham, Massachusetts-based diagnostic tools company developing solutions for embolization and founded in 2017 by Amarpreet Sawhney.
Associated investment funds
VP of Finance
Joshua S. Phillips
Documentaries, videos and podcasts